Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway. [electronic resource]
Producer: 20170310Description: 2704-12 p. digitalISSN:- 1791-2423
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Doxorubicin -- pharmacology
- Drug Synergism
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Melphalan -- pharmacology
- Multiple Myeloma -- drug therapy
- NF-kappa B -- metabolism
- Signal Transduction -- drug effects
- Vincristine -- pharmacology
- Xanthones -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.